706. In Vitro Activity of Ceftazidime–Avibactam and Comparator Agents Against MDR Enterobacteriaceae and Pseudomonas aeruginosa Collected in Latin America During the ATLAS Global S...

Por Lob, Sibylle, Kazmierczak, Krystyna, Stone, Gregory, Sahm, Daniel F
Publicado no Open Forum Infect Dis (2019)

680. In vitro Activity of Ceftazidime–Avibactam and Comparator Agents Against Pseudomonas aeruginosa from ICU and Non-ICU Wards Collected in Latin America and Globally as Part of t...

Por Lob, Sibylle, Kazmierczak, Krystyna, Stone, Gregory, Sahm, Daniel F
Publicado no Open Forum Infect Dis (2019)

Activity of Ceftolozane-Tazobactam Against Global Pseudomonas Aeruginosa and Non-Susceptible Phenotypes: SMART 2016

Por Lob, Sibylle, Hackel, Meredith, Badal, Robert, Young, Katherine, Motyl, Mary, Sahm, Dan
Publicado no Open Forum Infect Dis (2017)

413 In Vitro Activity of Tigecycline against Commonly-Isolated Pathogens of Skin and Skin Structure Infections in the United States – TEST 2011-2013

Por Hackel, Meredith, Lob, Sibylle, Bouchillon, Samuel, Sahm, Dan, Hoban, Daryl, Leister-Tebbe, Heidi
Publicado no Open Forum Infect Dis (2014)

1355. Global Activity of Imipenem–Relebactam and Comparators Against Clinical Gram-Negative Pathogens – SMART 2017

Por Lob, Sibylle, Kazmierczak, Krystyna, Hoban, Daryl, Hackel, Meredith, Young, Katherine, Motyl, Mary, Sahm, Dan
Publicado no Open Forum Infect Dis (2018)

709. Activity of Key β-Lactam Agents Against Gram-Negative Bacilli From ICU Patients with Lower Respiratory Tract Infections, SMART United States 2015–2017

Por Lob, Sibylle, Kazmierczak, Krystyna, Hoban, Daryl, Hackel, Meredith, Young, Katherine, Motyl, Mary, Sahm, Dan
Publicado no Open Forum Infect Dis (2018)

718. Activity of Ceftolozane–Tazobactam and Ceftazidime–Avibactam Against Clinical P. aeruginosa Isolates Collected in United States and Canada—SMART 2018

Por Lob, Sibylle, Kazmierczak, Krystyna, Raddatz, Janet, DePestel, Daryl, Young, Katherine, Motyl, Mary, Sahm, Daniel F
Publicado no Open Forum Infect Dis (2019)

597. Cross-resistance of Ceftolozane-Tazobactam and Imipenem-Relebactam Against Clinical P. aeruginosa Isolates: SMART United States 2016–2018

Por Lob, Sibylle, Kazmierczak, Krystyna, DePestel, Daryl, Raddatz, Janet, Young, Katherine, Motyl, Mary, Sahm, Daniel F
Publicado no Open Forum Infect Dis (2019)

418 Antimicrobial Profile of Enterobacteriaceae from North America from 2013

Por Johnson, Brian, Johnson, Jack, Bouchillon, Samuel, Hoban, Daryl, Hackel, Meredith, Lob, Sibylle, Biedenbach, Douglas, Leister-Tebbe, Heidi
Publicado no Open Forum Infect Dis (2014)

In Vitro Activity of Imipenem-Relebactam against Clinical Isolates of Gram-Negative Bacilli Isolated in Hospital Laboratories in the United States as Part of the SMART 2016 Program

Por Karlowsky, James A., Lob, Sibylle H., Kazmierczak, Krystyna M., Young, Katherine, Motyl, Mary R., Sahm, Daniel F.
Publicado no Antimicrob Agents Chemother (2018)

In Vitro Activity of Eravacycline against Gram-Negative Bacilli Isolated in Clinical Laboratories Worldwide from 2013 to 2017

Por Morrissey, Ian, Olesky, Melanie, Hawser, Stephen, Lob, Sibylle H., Karlowsky, James A., Corey, G. Ralph, Bassetti, Matteo, Fyfe, Corey
Publicado no Antimicrob Agents Chemother (2020)

In Vitro Activity of Imipenem-Relebactam against Gram-Negative ESKAPE Pathogens Isolated by Clinical Laboratories in the United States in 2015 (Results from the SMART Global Survei...

Por Lob, Sibylle H., Hackel, Meredith A., Kazmierczak, Krystyna M., Young, Katherine, Motyl, Mary R., Karlowsky, James A., Sahm, Daniel F.
Publicado no Antimicrob Agents Chemother (2017)

In Vitro Activity of Imipenem against Carbapenemase-Positive Enterobacteriaceae Isolates Collected by the SMART Global Surveillance Program from 2008 to 2014

Por Karlowsky, James A., Lob, Sibylle H., Kazmierczak, Krystyna M., Badal, Robert E., Young, Katherine, Motyl, Mary R., Sahm, Daniel F.
Publicado no J Clin Microbiol (2017)

Trends in Susceptibility of Escherichia coli from Intra-Abdominal Infections to Ertapenem and Comparators in the United States According to Data from the SMART Program, 2009 to 201...

Por Lob, Sibylle H., Kazmierczak, Krystyna M., Badal, Robert E., Hackel, Meredith A., Bouchillon, Samuel K., Biedenbach, Douglas J., Sahm, Daniel F.
Publicado no Antimicrob Agents Chemother (2015)

In Vitro Activity of Eravacycline against Gram-Positive Bacteria Isolated in Clinical Laboratories Worldwide from 2013 to 2017

Por Morrissey, Ian, Hawser, Stephen, Lob, Sibylle H., Karlowsky, James A., Bassetti, Matteo, Corey, G. Ralph, Olesky, Melanie, Newman, Joseph, Fyfe, Corey
Publicado no Antimicrob Agents Chemother (2020)